FDA official logo
GSRS logo
PFDA official logo

ATAZANAVIR SULFATE

  • UNII: 4MT4VIE29P
  • Formula: C38H52N6O7.H2O4S
  • Preferred Substance Name: ATAZANAVIR SULFATE
  • InChIKey: DQSGVVGOPRWTKI-QVFAWCHISA-N

  • 229975-97-7
  • 2,5,6,10,13-PENTAAZATETRADECANEDIOIC ACID, 3-12-BIS(1,1-DIMETHYLETHYL)-8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)-6-((-4-(2-PYRIDINYL)PHENYL)METHYL)-, DIMETHYL ESTER, (3S,8S,9S,12S)-, SULFATE (1:1) (SALT)
  • 2,5,6,10,13-PENTAAZATETRADECANEDIOIC ACID, 3-12-BIS(1,1-DIMETHYLETHYL)-8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)-6-((-4-(2-PYRIDINYL)PHENYL)METHYL)-, DIMETHYL ESTER, (3S,8S,9S,12S)-, SULPHATE (1:1) (SALT)
  • ATAZANAVIR SO4
  • ATAZANAVIR SO4 [VANDF]
  • ATAZANAVIR SULFATE [EP MONOGRAPH]
  • ATAZANAVIR SULFATE [JAN]
  • ATAZANAVIR SULFATE [MART.]
  • ATAZANAVIR SULFATE [MI]
  • ATAZANAVIR SULFATE [ORANGE BOOK]
  • ATAZANAVIR SULFATE [USAN]
  • ATAZANAVIR SULFATE [USP-RS]
  • ATAZANAVIR SULFATE [WHO-DD]
  • ATAZANAVIR SULFATE [WHO-IP]
  • ATAZANAVIR SULFATE COMPONENT OF EVOTAZ
  • ATAZANAVIR SULPHATE
  • ATAZANAVIR SULPHATE [EMA EPAR]
  • ATAZANAVIRI SULFAS [WHO-IP LATIN]
  • ATAZOR
  • BMS-232632-05
  • DIMETHYL (3S,8S,9S,12S)-9-BENZYL-3,12,DI-TERT-BUTYL-8-HYDROXY-4,11-DIOXO-6-(P-2-PYRIDYLBENZYL)-2,5,6,10,13-PENTAAZATETRADECANEDIOATE, SULFATE (1:1) (SALT)
  • DIMETHYL (3S,8S,9S,12S)-9-BENZYL-3,12,DI-TERT-BUTYL-8-HYDROXY-4,11-DIOXO-6-(P-2-PYRIDYLBENZYL)-2,5,6,10,13-PENTAAZATETRADECANEDIOATE, SULPHATE (1:1) (SALT)
  • DIMETHYL (3S,8S,9S,12S)-9-BENZYL-3,12-DI-TERT-BUTYL-8-HYDROXY-4,11-DIOXO-6-((4-(PYRIDIN-2-YL)PHENYL)METHYL)-2,5,6,10,13-PENTAAZATETRADECANEDIOATE MONOSULFATE
  • EVOTAZ COMPONENT ATAZANAVIR SULFATE
  • NSC-742546
  • REYATAZ

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.